Target intelligence / Profile preview

Synovial fluid lipid membrane and associated extracellular components (SAPL)

Target
SAPL
Molecular classification
Lipid, Extracellular matrix component, Other
01

Overview

Synovial fluid lipid membranes and associated extracellular components, such as surface-active phospholipids (SAPL), hyaluronic acid, and lubricin, constitute a critical functional system for maintaining joint health and mobility. These components organize into complex layers on the articular cartilage surface and within the synovial fluid to provide boundary lubrication, which significantly reduces friction and mechanical wear during joint movement (Jay & Waller, 2014). The primary lipid component, dipalmitoylphosphatidylcholine (DPPC), acts as a surfactant that coats the cartilage, while hyaluronic acid provides viscosity and lubricin facilitates the sliding of surfaces under high loads (Hills, 2002). In degenerative conditions like osteoarthritis, the concentration and structural integrity of these lipids and proteins are compromised, leading to increased joint friction, inflammation, and progressive cartilage destruction (Kretzer et al., 2012). Therapeutic strategies targeting this system include viscosupplementation with exogenous hyaluronic acid and the development of synthetic lipid-based lubricants to restore the protective boundary layer. These interventions aim to alleviate pain and improve joint function by mimicking the natural lubricating properties of the synovial environment.

Other names
Surface-active phospholipidsArticular cartilage surface lipidsSynovial boundary lubricant complexSynovial surfactant
02

Mechanism of action

Restoration of the boundary lubrication layer and enhancement of synovial fluid viscosity to reduce mechanical friction and wear on articular surfaces.

03

Biological functions

Joint lubricationBoundary lubricationMechanical protectionFriction reduction
04

Disease associations

OsteoarthritisRheumatoid arthritisJoint dysfunction
05

Safety considerations

Injection site painSeptic arthritis riskTransient joint inflammationHypersensitivity reactions
06

Interacting drugs

Hyaluronic acid

3 more in the full profile.

07

Biomarkers

Synovial fluid phospholipid concentrationHyaluronic acid molecular weight distributionLubricin (PRG4) levels

Beyond the preview

Go deeper on Synovial fluid lipid membrane and associated extracellular components (SAPL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synovial fluid lipid membrane and associated extracellular components (SAPL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call